🇺🇸 FDA
Patent

US 7964559

MVL, an antiviral protein from a cyanobacterium

granted A61PA61P31/12

Quick answer

US patent 7964559 (MVL, an antiviral protein from a cyanobacterium) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61P, A61P31/12